Trial intelligence / Profile preview

Naltrexone Implant vs Oral in HIV+ Opioid Dependence

NCT01101815Phase 2Completed

Sponsor
University of Pennsylvania
Start
Jun 2010
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naltrexone in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Jun 2010; status: completed.

02

Drugs

naltrexone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT01101815.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01101815.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call